D-0361-2024 Class II Ongoing
FDA drug recall D-0361-2024 was initiated by Denver Solutions, LLC DBA Leiters Health on Feb 20, 2024 and is designated Class II. Reason for recall: Presence of Particulate Matter: glass vials from the manufacturer showed signs of glass delamination. The recall status is ongoing. Affected quantity: 40,090 vials.
Recall details
- Product Type
- Drugs
- Report Date
- Mar 6, 2024
- Initiation Date
- Feb 20, 2024
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 40,090 vials
Product description
Moxifloxacin PF, 1mg/ml, in Sterile Balanced Salt Solution (BSS) Sterile injection, Intracameral Use Only, Single- Dose Vial, Leiters 13796 Compark Blvd, Englewood, CO 80112, NDC 71449-096-42
Reason for recall
Presence of Particulate Matter: glass vials from the manufacturer showed signs of glass delamination.
Distribution pattern
Nationwide in the USA
Code information
Lot #:2331147, Exp:6-Mar-24; 2331180, Exp: 21-Mar-24; 2331256, Exp: 2-Apr-24; 2331279, Exp: 3-Apr-24; 2331283, Exp: 7-Apr-24; 2331345, Exp: 20-Apr-24; 2331422, Exp: 27-Apr-24; 2331563, Exp: 29-May-24.
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0361-2024
- openFDA file date
- Nov 10, 2026
- Loaded by RegDataLab
- Nov 11, 2026